Mechanisms of mycotoxin-induced dermal toxicity and tumorigenesis through oxidative stress-related pathways

Journal of Toxicologic Pathology

Volumn 27, Issue 1, 2014, Pages 1-10

  Doi, Kunio ^a,b   Uetsuka, Koji ^c  

^a Research Center Inc   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c IBARAKI UNIVERSITY   (Japan)

Author keywords

Aflatoxin B1; Citrinin; Dermal toxicity; Dermal tumorigenesis; Ochratoxin A; Patulin; T 2 toxin

Indexed keywords

AFLATOXIN B1; CITRININ; CYCLIN D1; CYCLOOXYGENASE 2; CYTOKINE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYCOTOXIN; OCHRATOXIN; PATULIN; PROTEIN C FOS; PROTEIN C JUN; REACTIVE OXYGEN METABOLITE; T 2 TOXIN; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; CELL PROLIFERATION; DERMIS; DNA DAMAGE; ENZYME ACTIVATION; EPIDERMIS; HYPERPLASIA; KERATINOCYTE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN TOXICITY; TUMOR PROMOTION;

EID: 84899899539     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.2013-0062     Document Type: Review

References (128)

1. Haschek WM, Voss KA, and Beasley VR. Selected mycotoxins affecting animal and human health. In: Handbook of Toxicologic Pathology, 2nd ed. WM Haschek, CG Rousseaux, and MA Walling (eds). Academic Press, San Diego. 645-699. 2002.
2. Chandra J, and Samali A. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med. 29: 323-333. 2000. [Medline] [CrossRef]
3. Sehata S, Kiyosawa N, Makino T, Atsumi F, Ito K, Yamoto T, Teranishi M, Baba Y, Uetsuka K, Nakayama H, and Doi K. Morphological and microarray analysis of T-2 toxin-induced rat fetal brain lesion. Food Chem Toxicol. 42: 1727-1736. 2004. [Medline] [CrossRef]
4. Shinozuka J, Miwa S, Fujimura H, Toriumi W, and Doi K. Hepatotoxicity of T-2 toxin, trichothecene mycotoxin. In: New Strategies for Mycotoxin Research in Asia (Proceedings of ISMYCO Bangkok '06). S Kumagai (ed). Japanese Association of Mycotoxicology, Tokyo. 62-66. 2007.
5. Doi K, Ishigami N, and Sehata S. T-2 toxin-induced toxicity in pregnant mice and rats. Int J Mol Sci. 9: 2146-2158. 2008. [Medline] [CrossRef]
6. Surai PF, Mezes M, Melnichuk SD, and Fotina TI. Mycotoxins and animal health: From oxidative stress to gene expression. Krmiva. 50: 35-43. 2008.
7. Doi K, and Uetsuka K. Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways. Int J Mol Sci. 12: 5213-5237. 2011. [Medline]
8. FAO. Manuals of Food Quality Control. 10. Training in Mycotoxin Analysis. Food and Agriculture Organization of the United Nations, Rome. 4-10. 1990.
9. WHO. Safety Evaluation of Certain Mycotoxins in Food Prepared by 49th meeting of JECFA Food Additives Series 47. WHO, Geneva. 1998.
10. Albarenque SM, Shinozuka J, Iwamoto S, Nakayama H, and Doi K. T-2 toxin-induced acute skin lesions in Wistarderived hypotrichotic WBN/ILA-Ht rats. Histol Histopathol. 14: 337-342. 1999. [Medline]
11. Bennett JW, and Klich M. Mycotoxins. Clin Microbiol Rev. 16: 497-516. 2003. [Medline] [CrossRef]
12. Kumar R, Dwivedi PD, Dhawan A, Das M, and Ansari KM. Citrinin-generated reactive oxygen species cause cell cycle arrest leading to apoptosis via the intrinsic mitochondrial pathway in mouse skin. Toxicol Sci. 122: 557-566. 2011. [Medline] [CrossRef]
13. Riley RT, Kemppainen BW, and Norred WP. Penetration of aflatoxins through isolated human epidermis. J Toxicol Environ Health. 15: 769-777. 1985. [Medline] [CrossRef]
14. Kemppainen BW, Riley RT, and Pace JG. Skin absorption as a route of exposure for aflatoxin and trichothecenes. J Toxicol. 7: 95-120. 1988.
15. Rastogi S, Dogra RKS, Khanna SK, and Das M. Skin tumorigenic potential of afratoxin B1 in mice. Food Chem Toxicol. 44: 670-677. 2006. [Medline] [CrossRef]
16. 3H] T-2 toxin in the rat model. J Toxicol Environment Health. 26: 413-423. 1989. [CrossRef]
17. Blaylock BL, Kouchi Y, Comment CE, Pollock PL, and Luster MI. Topical application of T-2 toxin inhibits the contact hypersensitivity response in BALB/c mice. J Immunol. 150: 5135-5143. 1993. [Medline]
18. Chaudhary M, and Rao PV. Brain oxidative stress after dermal and subcutaneous exposure of T-2 toxin in mice. Food Chem Toxicol. 48: 3436-3442. 2010. [Medline] [CrossRef]
19. Boonen J, Malysheva SV, Taevernier L, Diana Di Mavungu J, De Saeger S, and De Spiegeleer B. Human skin penetration of selected mycotoxins. Toxicology. 301: 21-32. 2012. [Medline] [CrossRef]
20. Schiefer HB, and Hancock DS. Systemic effects of topical application of T-2 toxin in mice. Toxicol Appl Pharmacol. 76: 464-472. 1984. [Medline] [CrossRef]
21. Pang VF, Swanson SP, Beasley VR, Buck WB, and Hascheck WM. The toxicity of T-2 toxin in swine following topical application. Fundam Appl Toxicol. 9: 41-49. 1987. [Medline] [CrossRef]
22. Yarom R, Bergmann F, and Yagen B. Cutaneous injury by topical T-2 toxin: involvement of microvessels and mast cells. Toxicon. 25: 167-174. 1987. [Medline] [CrossRef]
23. Bhavanishankar TN, Ramesh SH, and Shantha T. Dermal toxicity of Fusarium toxins in combinations. Arch Toxicol. 61: 241-244. 1988. [Medline] [CrossRef]
24. Biehl ML, Lambert RJ, Haschek WM, Buck WB, and Schaeffer DJ. Evaluation of a superactivated charcoal paste and detergent and water in prevention of T-2 toxin-induced local cutaneous effects in topically exposed swine. Fundam Appl Toxicol. 13: 523-532. 1989. [Medline] [CrossRef]
25. Hemmati AA, Kalantari H, Jalali A, Rezai S, and Zadeh HH. Healing effect of quince seed mucilage on T-2 toxininduced dermal toxicity in rabbit. Exp Toxicol Pathol. 64: 181-186. 2012. [Medline] [CrossRef]
26. 21/WAF1 proteins in skin of mice. Toxicol Appl Pharmacol. 234: 192-201. 2009. [Medline] [CrossRef]
27. Saxena N, Ansari M, Kumar R, Chaudhari BP, Dwivedi PD, and Das M. Role of mitogen activated protein kinases in skin tumorigenicity of Patrin. Toxicol Appl Pharmacol. 257: 264-271. 2011. [Medline] [CrossRef]
28. Kumar R, Alam S, Chaudhari BP, Dwivedi PD, Jain SK, Ansari KM, and Das M. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappaB and activator protein-1. Carcinogenesis. 34: 647-657. 2013. [Medline] [CrossRef]
29. Kumar R, Ansari KM, Chaudhari BP, Dhawan A, Dwivedi PD, Jain SK, and Das M. Topical application of ochratoxin A causes DNA damage and tumor initiation in mouse skin. PLoS One. 7(10): e47280. 2012; published online; DOI 10.1371/journal.pone.0047280 [CrossRef]. [Medline]
30. Desjardins AE, Hohn TM, and McComic SP. Trichothecene biosynthesis in Fusarium species: chemistry, genetics, and significance. Microbiol Rev. 57: 595-604. 1993. [Medline]
31. Nelson PE, Dignani MC, and Anaissie EJ. Toxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev. 7: 479-504. 1994. [Medline]
32. Eriksen GS, and Petterson H. Toxicological evaluation of trichothrcenes in animal feed. Anim Feed Sci Technol. 114: 205-239. 2004. [CrossRef]
33. Shifrin VI, and Anderson P. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-jun Nterminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J Biol Chem. 274: 13985-13992. 1999. [Medline] [CrossRef]
34. Thompson WL, and Wannemacher RWH Jr. In vitro effects of T-2 mycotoxin on synthesis of protein and DNA in rat tissues. Toxicol Appl Pharmacol. 105: 483-491. 1990. [Medline] [CrossRef]
35. Chang IM, and Mar WC. Effect of T-2 toxin on lipid peroxidation in rats: Evaluation of conjugated dien formation. Toxicol Lett. 40: 275-280. 1988. [Medline] [CrossRef]
36. Sundstol Eriksen G, Petterson H, and Lund H. Comparative cytotoxicity of deoxynivalenol, nivalenol, triacetylated derivatives and de-epoxy metabolites. Food Chem Toxicol. 42: 619-624. 2004. [Medline] [CrossRef]
37. Iwamoto S, Nakayama H, and Doi K. Morphological and morphometrical study on the dorsal skin of Wistar and WBN/ILA-Ht rats in their developing stage. Evaluation of the proliferation and apoptotic processes. Histol Histopathol. 13: 981-988. 1998. [Medline]
38. Malcotti V, Yasoshima A, Imaoka K, Nakayama H, and Doi K. Dorsal skin responses to subchronic ultraviolet B (UVB)-irradiation in Wistar-derived hypotrichotic WBN/ ILA-Ht rats. Histol Histopathol. 17: 683-690. 2002. [Medline]
39. Albarenque SM, Suzuki K, Nakayama H, and Doi K. Kinetics of cytokines mRNAs expression in the dorsal skin of WBN/ILA-Ht rats following topical application of T-2 toxin. Exp Toxicol Pathol. 53: 271-274. 2001. [Medline] [CrossRef]
40. Albarenque SM, Suzuki K, Shinozuka J, Nakayama H, and Doi K. Kinetics of apoptosis-related mRNA expression in the dotsal skin of hypotrichotic WBN/ILA-Ht rats after topical application of T-2 toxin. Exp Toxic Pathol. 52: 553-556. 2001. [CrossRef]
41. Albarenque SM, Shinozuka J, Suzuki K, Nakayama H, and Doi K. Kinetics and distribution of transforming growth factor (TGF)-β1 mRNA in the dorsal skin of hypotrichotic WBN/ILA-Ht rats following topical application of T-2 toxin. Exp Toxicol Pathol. 52: 297-301. 2000. [Medline] [CrossRef]
42. Albarenque SM, and Doi K. T-2 toxin-induced apoptosis in rat keratinocyte primary cultures. Exp Mol Pathol. 78: 144-149. 2005. [Medline] [CrossRef]
43. Mils V, Piette J, Barette C, Veyrune J, Tesniere A, Escot C, Guilhou J, and Basset-Seguin N. The proto-oncogene c-fos increases the sensitivity of keratinocytes to apoptosis. Oncogene. 14: 1555-1561. 1997. [Medline] [CrossRef]
44. Collotta F, Polentarutti N, Sironi M, and Mantovani A. Expression and involvement of c-fos and c-jun proto-oncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem. 267: 18278-18283. 1992. [Medline]
45. Smeyne RJ, Vendrell M, Hayward M, Baker S, Miao G, Schiling K, Robertson L, Curran T, and Morgan J. Continuous c-fos expression precedes programmed cell death in vivo. Nature. 363: 166-169. 1993. [Medline] [CrossRef]
46. Barker JN, Mitra R, and Griffiths C. Keratinocytes as indicators of inflammation. Lancet. 337: 211-214. 1991. [Medline] [CrossRef]
47. Nickoloff BJ, and Naidu Y. Perturbation of epidermal barrier function correlates with inhibition of cytokine cascade in human skin. J Am Acad Dermatol. 30: 535-546. 1994. [Medline] [CrossRef]
48. Köck A, Urbanski A, and Luger T. mRNA expression and release of tumor necrosis factor-alpha by human epidermal cells. J Invest Dermatol. 92: 462A. 1989 (Abstract).
49. Schwarz A, Bhardwaj R, Aragane Y, Manhnke K, Riemann K, Metze D, Luger T, and Schwarz T. Ultraviolet B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-α in the formation of sunburn cells. J Invest Dermatol. 104: 922-927. 1995. [Medline] [Cross-Ref]
50. Meng X, Sawamura D, Baba T, Ina S, Itai K, Hanada K, and Hashimoto I. TNF-α causes apoptosis in epidermal keratinocytes after subcutaneous injection of TNF-α plasmid. J Invest Dermatol. 113: 856-857. 1999. [Medline] [Cross-Ref]
51. Zhuang L, Wang B, Shinder G, Shivji G, Marl T, and Sander D. TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J Immunol. 162: 1440-1447. 1999. [Medline]
52. Fowlis DJ, Flanders K, Duffie D, Balmain A, and Akhurst R. Discordant transforming growth factor β1 RNA and protein localization during chemical carcinogenesis of the skin. Cell Growth Differ. 3: 81-91. 1992. [Medline]
53. 3, transforminf growth factor-β1, calcium, and ultraviolet B radiation induce apoptosis in cultured human keratinocytes. J Invest Dermatol. 109: 276-282. 1997. [Medline] [CrossRef]
54. Iordanov MS, Pribnow D, Magun J, Din T, Pearson J, and Magun B. Ultraviolet radiation triggers the ribotoxic stress response in mammalian cells. J Biol Chem. 273: 15794-15803. 1998. [Medline] [CrossRef]
55. Shinozuka J, Tsutsui S, Ishigami N, Ueno-Yamanouchi A, Nakayama H, and Doi K. Development of apoptosis and changes in apoptosis-related genes expression in the mouse thymus following T-2 toxin-inoculation. J Toxicol Pathol. 12: 77-81. 1999. [CrossRef]
56. Sehata S, Kiyosawa N, Atsumi F, Ito K, Yamoto T, Teranishi M, Uetsuka K, Nakayama H, and Doi K. Microarray analysis of T-2 toxin-induced liver, placenta and fetal liver lesions in pregnant rats. Exp Toxicol Pathol. 57: 15-28. 2005. [Medline] [CrossRef]
57. Lambert LA, Hines FA, and Eppley RM. Lack of initiation and promotion potential of deoxynivalenol for skin tumorigenesis in Sencer mice. Food Chem Toxicol. 33: 217-222. 1995. [Medline] [CrossRef]
58. Flajs D, and Peracia M. Toxicological properties of citrinin. Arh. Hig Rada Toksikol. 60: 457-464. 2009. [Medline]
59. CAST. Mycotoxins: Risks in Plant, Animal, and Human Systems. Council of Agricultural Science and Technology. Task force report No. 139. CAST, Ames. 2003.
60. Carlton WW, and Tuite J. Metabolites of P. viridicatum toxicology. In: Mycotoxins in Human and Animal Health. JV Rodricks, CW Hesseltine, and MA Mehlman (eds). Pathotox Publications Inc., Illinoi. 525-555. 1977.
61. Aleo MD, Wyatt RD, and Schnellmann RG. Mitochondrial dysfunction in an early event in ochratoxin A but not oosporein toxicity to rat renal proximal tubules. Toxicol Appl Pharmacol. 107: 73-80. 1991. [Medline] [CrossRef]
62. Arai M, and Hibino T. Tumorigenicity of citrinin in male F344 rats. Cancer Lett. 17: 281-287. 1983. [Medline] [CrossRef]
63. Kitabatake N, Doi E, and Trivedi AB. Toxicity evaluation of the mycotoxins, citrinin and ochratoxin A, using several animal cell lines. Comp Biochem Physiol C. 105: 429-433. 1993. [Medline] [CrossRef]
64. Liu BH, Yu FY, Wu TS, Li SY, Su MC, Wang MC, and Shi SM. Evaluation of genotoxic risk and oxidative DNA damage in mammalian cells exposed to mycotoxins, patulin and citrinin. Toxicol Appl Pharmacol. 191: 255-263. 2003. [Medline] [CrossRef]
65. Yu FY, Liao YC, Chang CH, and Liu BH. Citrinin induces apoptosis in HL-60 cells via activation of the mitochondrial pathway. Toxicol Lett. 161: 143-151. 2006. [Medline] [CrossRef]
66. Chan WH. Citrinin induces apoptosis via a mitochondriadependent pathway and inhibition of survival signals in embryonic stem cells, and causes developmental injury in blastocysts. Biochem J. 404: 317-326. 2007. [Medline]
67. Chan WH. Citrinin induces apoptosis in mouse embryonic stem cells. IUBMB Life. 60: 171-179. 2008. [Medline] [CrossRef]
68. Chen CC, and Chan WH. Inhibition of citrinin-induced apoptoptotic biochemical signaling in human hepatoma G2 cells by resveratol. Int J Mol Sci. 10: 3338-3357. 2009. [Medline] [CrossRef]
69. Abbas T, and Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 9: 400-414. 2009. [Medline] [CrossRef]
70. Jiang L, Sheikh MS, and Huang Y. Decision making by p53: life versus death. Mol Cell Pharmacol. 2: 69-77. 2010. [Medline]
71. Das M, Ansari KM, Dhawan A, Shukla Y, and Khanna SK. Correlation of DNA damage in Epidemic Dropsy patients to carcinogenic potential of argemone oil and isolated sanguinarine alkaloid in mice. Int J Cancer. 117: 709-717. 2005. [Medline] [CrossRef]
72. Puel O, Galtier P, and Oswald IP. Biosynthesis and toxicological effects of patulin. Toxins. 2: 613-631. 2010. [Medline] [CrossRef]
73. IARC. Some naturally occurring and synthetic food components, furocoumarins and ultraviolet radiation. In: IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. IARC, Lyon. 83-98. 1986.
74. Barhoumi R, and Burghardt RC. Kinetic analysis of the chronology of patulin and gossypol-induced cytotoxicity in vitro. Fundam Appl Toxicol. 30: 290-297. 1996. [Medline] [CrossRef]
75. Liu BH, Wu TS, Yu FY, and Su CC. Induction of oxidative stress response by the mycotoxin Patulin in mammalian cells. Toxicol Sci. 95: 340-347. 2007. [Medline] [Cross-Ref]
76. Thust R, Kneist S, and Mendel J. Patulin, a further clastogenic mycotoxin, is negative in the SCE assay in Chinese hamster V79-E cells in vitro. Mutat Res. 103: 91-97. 1982. [Medline] [CrossRef]
77. Alves I, Olivria NG, Laires A, Rodrigues AS, and Rueff J. Induction of micronuclei and chromosomal aberrations by the mycotoxin patulin in mammalian cells: role of ascorbic acid as modulator of patulin clastogenicity. Mutagenesis. 15: 229-234. 2000. [Medline] [CrossRef]
78. Wu TS, Yu FY, Su CC, Kan JC, Chung CP, and Liu BH. Activation of ERK mitogen-activated protein kinase in human cells by the mycotoxin patulin. Toxicol Appl Pharmacol. 207: 103-111. 2005. [Medline] [CrossRef]
79. Liu BH, Wu TS, Yu FY, and Wang H. Mycotoxin patulin activates the p38 kinase and JNK signaling pathways in human embryonic kidney cells. Toxicol Sci. 89: 423-430. 2006. [Medline] [CrossRef]
80. Lehman L, Franz U, and Metzler M. Genotoxic potential of the mycotoxin patulin in cultured mammalial fibroblasts. Naunyn-Schmiedeberg's Arch Pharmacol. 367: R166. 2003.
81. Tantini B, Fiumana E, Cetrullo S, Pignatti C, Bonavita F, Shantz LM, Giordano E, Muscari C, Flamigni F, Guarnieri C, Stefanelli C, and Caldarera CM. Involvement of polyamines in apoptosis of cardiac myoblasts in a model of stimulated ischemia. J Mol Cell Cardiol. 40: 775-782. 2006. [Medline] [CrossRef]
82. Thomas T, and Thomas TJ. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci. 58: 244-258. 2001. [Medline] [CrossRef]
83. Wallace HM, Fraser AV, and Hughes A. A perspective of polyamine metabolism. Biochem J. 376: 1-14. 2003. [Medline] [CrossRef]
84. Wei G, Defeo K, Hayes CS, Woster PM, Nayak LM, and Gilmour SK. Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes. Cancer Res. 68: 2214-2222. 2008. [Medline] [CrossRef]
85. Benhar M, Engelberg D, and Levitzki A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep. 3: 420-425. 2002. [Medline] [CrossRef]
86. Chung JH, Kang S, Varani J, Lin J, Fischer GJ, and Voorhees JJ. Decreased extracellular signal regulated kinase and increased stress activated MAP kinase activities in aged human skin in vivo. J Invest Dermatol. 115: 177-182. 2000. [Medline] [CrossRef]
87. Takahashi H, Ibe M, Nakamura S, Ishida-Yamamoto A, Hasimoto Y, and Iizuka H. Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis. J Dermatol Sci. 30: 94-99. 2002. [Medline] [CrossRef]
88. Pfeiffer E, Gross K, and Metzler M. Aneuploidogenic and clastogenic potential of the mycotxins citrinin and patulin. Carcinogenesis. 19: 1313-1318. 1998. [Medline] [Cross-Ref]
89. Dickens F, and Jones HEH. Carcinogenic activity of a series of reactive lactones and related substances. Br J Cancer. 15: 85-100. 1961. [Medline] [CrossRef]
90. Osswald H, Frank HK, Komitowski D, and Winter H. Longterm testing of patulin administered orally to Sprague-Dawley rats and Swiss mice. Food Cosmet Toxicol. 16: 243-247. 1978. [Medline] [CrossRef]
91. Goto T, Wicklow DT, and Ito Y. Aflatoxin and cyclopiazonic acid production by a sclerotium-producing Aspergillus tamari strain. Appl Environ Microbiol. 62: 4036-4038. 1996. [Medline]
92. Busby W, and Wogan G. Aflatoxins. Chemical carcinogens. Am Chem Soc Monogr. 2: 954-1136. 1984.
93. Roebuck BD, and Maxuitenko YY. In: The toxicology of aflatoxins. In: Human health, veterinary and agricultural significance, DL E, and ID G (eds). Academic Press, San Diego. 27-44. 1994.
94. Anonymous Manuals of food quality control. 10. Training in mycotoxin analysis. Food and Agriculture Organization of the United Nations, Rome, 1990.
95. Raney KD, Coles B, Guengerich FP, and Harris TM. The endo-8,9-epoxide of aflatoxin B1: a new metabolite. Chem Res Toxicol. 5: 333-335. 1992. [Medline] [CrossRef]
96. Shen HM, Shi CY, Lee HP, and Ong CN. Aflatoxin B1-induced lipid peroxidation in rat liver. Toxicol Appl Pharmacol. 127: 145-150. 1994. [Medline] [CrossRef]
97. Amstad P, Levy A, Emerit I, and Certti P. Evidence for membrane-mediated chromosomal damage by aflatoxin B1 in human lymphocytes. Carcinogenesis. 5: 719-723. 1984. [Medline] [CrossRef]
98. Rastogi S, Shukla Y, Paul BN, Chowdhuri DK, Khanna SK, and Das M. Protective effect of Ocimum sanctum on 3-methylcholanthrene, 7,12-dimethylbenz(a)anthracene and aflatoxin B1 induced skin tumorigenesis in mice. Toxicol Appl Pharmacol. 224: 228-240. 2007. [Medline] [CrossRef]
99. SCIR Wealth of India: A Dictionary of Indian Raw Materials and Industrial Products. Publications and Information Directorate, Council of Scientific and Industrial Research, New Delhi. 1996.
100. Prashar R, Kumar A, Hewer A, Cole KJ, Davis W, and Phillips DH. Inhibition by an extract of Ocimum sanctum of DNA-binding activity of 7,12-dimethylbenz[a]anthracene in rat hepatocytes in vitro. Cancer Lett. 128: 155-160. 1998. [Medline]
101. Karthikeyan K, Ravichandran P, and Govindasamy S. Chemopreventive effect of Ocimum sanctum on DMBAinduced hamster buccal carcinogenesis. Oral Oncol. 35: 112-119. 1999. [Medline] [CrossRef]
102. Uma Devi P. Radioprotective, anticarcinogenic and antioxidant properties of the Indian holy Basil, Ocimum sanctum (Tulai). Indian J Exp Biol. 39: 185-190. 2001. [Medline]
103. Aldaz CM, Conti CJ, and Larcher F. Sequential development of aneuploidy precedes keratin modification and γ-glutathione transferase expression in mouse skin papillomas. Cancer Res. 48: 3253-3257. 1988. [Medline]
104. Satoh K, Kitahara A, Soma Y, Halayami S, and Sato K. Purification, reduction and distribution of placental GST: a new marker enzyme for preneoplastic cells in the rat chemical carcinogenic. Proc Natl Acad Sci USA. 82: 3964-3968. 1985. [Medline] [CrossRef]
105. Ferrarini M, Heltai S, Zocchi MR, and Rugarli C. Unusual expression and localization of heat-scock proteins in human tumor cells. Int J Cancer. 51: 613-619. 1992. [Medline] [CrossRef]
106. Chowdhuri DK, Parmar D, Kakkar P, Shukla R, Seth PK, and Srimal RC. Antistress effects of bacosides of Bacopa monnieri: modulation of Hsp70 expression, superoxide dismutase and cytochrome p450 activity in rat brain. Phytother Res. 16: 639-645. 2002. [Medline] [CrossRef]
107. Cerutti PA. Peroxidant status and tumor promotion. Science. 227: 375-381. 1985. [Medline] [CrossRef]
108. Jang M, and Pezzuto JM. Effects of resveratrol on 12-Otetra decanoyl phorbol-13-acetate induced oxidative events and gene expression in mouse skin. Cancer Lett. 134: 81-89. 1998. [Medline] [CrossRef]
109. Galtier P. Pharmacokinetics of ochratoxin A in animals. IARC Sci Pub. 187-200. 1991.
110. Pfohl-Leszkowicz A, and Manderville RA. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res. 51: 61-99. 2007. [Medline]
111. Gareis M, and Wolff J. Relevance of mycotoxin contaminated feed for farm animals and carryover of mycotoxins to food of animal origin. Mycoses. 43: 79-83. 2000. [Medline]
112. Kuiper-Goodman T, Hilts C, Billiard SM, Kiparissis Y, Richard ID, and Hayward S. Health risk assessment of ochratoxin A for all age-sex strata in a market economy. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 27: 212-240. 2010. [Medline] [CrossRef]
113. Krogh P. Role of ochratoxin in disease causation. Food Chem Toxicol. 30: 213-224. 1992. [Medline] [CrossRef]
114. Lea T, Steinen K, and Stormer FC. Mechanism of ochratoxin A-induced immunosuppression. Mycopathologia. 107: 153-159. 1989. [Medline] [CrossRef]
115. Arora RG, Frolen H, and Fellner-Feldegg H. Inhibition of ochratoxin A teratogenesis by zearalenone and diethylstilbesteril. Food Chem Toxicol. 21: 779-783. 1983. [Medline] [CrossRef]
116. Pfohl-Leszkowicz A, Chakor K, Creppy EE, and Dirheimer G. DNA adduct formation in mice treated with ochratoxin A. IARC Sci Pub. 245-253. 1991.
117. Sava V, Reunova O, Velasquez A, Harbison R, and Sanchez-Ramos J. Acute neurotoxic effects of the fungal metabolite ochratoxin A. Neurotoxicology. 27: 82-92. 2006. [Medline] [CrossRef]
118. Kensler TW, Wakabayashi N, and Biswal S. Cell survival responses to environmental stress via Keap1-Nrf-2-ARE pathway. Ann Rev Pharmacol. 47: 89-116. 2007. [Cross-Ref]
119. O'Brien TG. The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res. 36: 2644-2653. 1976. [Medline]
120. Robles AI, and Conti CJ. Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis. 16: 781-786. 1995. [Medline] [CrossRef]
121. Hull MA. Cyclooxygenase-2: how good is it as a target for cancer chemoprevention? Eur J Cancer. 41: 1854-1863. 2005. [Medline] [CrossRef]
122. Dhillon AS, Hagan S, Rath O, and Kolch W. MAP kinase signaling pathways in cancer. Oncogene. 26: 3279-3290. 2007. [Medline] [CrossRef]
123. Marin-Kuan M, Nestler S, Verguet C, Benzencon C, Piguet D, Delatour T, Mantle P, Cavin C, and Schilter B. MAOPERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinoma. Toxicol Appl Pharmacol. 224: 174-181. 2007. [Medline] [CrossRef]
124. O'Brien E, and Dietrich DR. Ochratoxin A: the continuing enigma. Crit Rev Toxicol. 35: 33-60. 2005. [Medline] [CrossRef]
125. Rumora L, and Grubisc TZ. A journey through mitogen-activated protein kinase and Ochratoxin A interactions. Arh Hig Rada Toksikol. 60: 449-456. 2009. [Medline]
126. Segrelles C, Ruiz S, Peres P, Murga C, Santos M, Budunova IV, Martinez J, Larcher F, Slaga TJ, Gutkind JS, Jorcano JL, and Paramio JM. Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene. 21: 53-64. 2002. [Medline] [CrossRef]
127. Karin M, Liu ZG, and Zandi E. AP-1 function and regulation. Curr Opin Cell Biol. 9: 240-246. 1997. [Medline] [CrossRef]
128. Surh YJ, and Kundu JK. Signal transduction network leading to COX-2 induction: a road map in search of cancer chemoprevention. Arch Pharm Res. 28: 1-15. 2005. [Medline] [CrossRef]